Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Qihan Biotech Raises $16 Million for Gene-Edited Stem Cell Products 

publication date: Sep 25, 2023

Hangzhou Qihan Biotech closed a $16 million pre-B funding to support the company’s gene-edited stem cell products, including a lead product that has started China trials for CD19-positive B-cell non-Hodgkin lymphoma. Qihan says QN-019a is the first IND approved in China for a gene-edited Induced Pluripotent Stem Cells-derived cell therapy. The company uses multiplexable genome editing technology to modify iPSCs and differentiate them into a natural killer cell therapy product. The pre-B round was led by Zhejiang Industrial Fund. In 2021, Qihan raised $67 million in an A+ round. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here